JAK inhibitors for the treatment of inflammatory bowel disease: results of an international survey of perceptions, attitudes, and clinical practice

BACKGROUND: Janus kinase inhibitors (JAKi) are small molecule drugs with demonstrated efficacy in inflammatory bowel disease (IBD). However, widespread utilisation may be hindered by safety concerns. AIMS: This is the first study assessing risk-benefit perceptions and clinical practices of those usi...

Descripción completa

Detalles Bibliográficos
Autores principales: Honap, Sailish, Irving, Peter M., Samaan, Mark A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams And Wilkins 2023
Materias:
Original Articles: Gastroenterology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10659244/
https://www.ncbi.nlm.nih.gov/pubmed/37724470
http://dx.doi.org/10.1097/MEG.0000000000002650

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10659244/
https://www.ncbi.nlm.nih.gov/pubmed/37724470
http://dx.doi.org/10.1097/MEG.0000000000002650

Ejemplares similares